Skip to content

Author

P. Narendran

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Pancreatic β-cell mitogenic regeneration in type 1 diabetes: A preclinical review.

Type 1 diabetes (T1D) is caused by autoimmune destruction of insulin-producing pancreatic β-cells, resulting in hyperglycaemia. The first-line treatment for symptomatic T1D is exogenous insulin replacement to maintain glycaemic control. Islet transplant therapy is available to a small number of individuals, and stem ce...

J. Cantley, L. Logie, P. Narendran et al. · 0 citations
Review Open access Oct 2026

Professional Stakeholders' Perspectives on Early Screening for Type 1 Diabetes in Children: A Systematic Review

ABSTRACT Early screening for type 1 diabetes (T1D) is receiving increasing attention as presymptomatic screening initiatives and disease‐modifying therapies continue to expand. However, the perspectives of professional stakeholders, who play a pivotal role in implementation, patient engagement, and health system prepar...

F. Gatti, B. Milazzo, L. Quinn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.